Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
21
1kṀ34232026
7%
chance
1D
1W
1M
ALL
a black box warning by FDA or withdrawal from market for adverse events by 12/31/2025 resolves this market YES
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
Sort by:
made a related market and added a large subsidy: https://manifold.markets/AndyMartin/m5k-subsidy-will-any-fdaapproved-gl?r=QW5keU1hcnRpbg
More reports of gastroparesis https://www.cnn.com/2023/07/25/health/weight-loss-diabetes-drugs-gastroparesis/index.html
Related questions
Related questions
Will semaglutide be taken off FDA's drug shortage list in 2025?
65% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
15% chance
Will either Lada Nuzhan or Jose Luis Ricon give in and inject semaglutide/tirzepatide at least 3 times before EOY 2025?
48% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?
78% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
81% chance
Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
38% chance
Before 2033, will semaglutide be shown to improve lifespan, when prescribed to overweight people?
82% chance
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
17% chance